Amphastar Pharmaceuticals, Inc. (AMPH) Capital expenditures 2016–2025
Amphastar Pharmaceuticals, Inc. (AMPH) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$34.9MFY2025 · since FY2016: $21.4M → $34.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $34.9M | -15.0% |
| FY2024 | $41.0M | +7.5% |
| FY2023 | $38.2M | +58.8% |
| FY2022 | $24.0M | -12.5% |
| FY2021 | $27.5M | -18.9% |
| FY2020 | $33.9M | -18.5% |
| FY2019 | $41.6M | -11.2% |
| FY2018 | $46.8M | +33.4% |
| FY2017 | $35.1M | +64.2% |
| FY2016 | $21.4M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice